Role of Plasma Exchange in Steroid Resistant Neuromyelitis Optica with Loss of Vision
Published: October 1, 2020 | DOI: https://doi.org/10.7860/JCDR/2020/45701.14115
Ashish Maheshwari, Dnyaneshwar Shridharrao Patale, Trupti Lokhande, Smita Chouhan, Sana Mariyam
1. Assistant Professor, Department of Transfusion Medicine, ILBS, New Delhi, India.
2. Senior Resident, Department of Transfusion Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
3. Senior Resident, Department of Transfusion Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
4. Senior Resident, Department of Transfusion Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
5. Junior Resident, Department of Transfusion Medicine, AIIMS, Bhopal, Madhya Pradesh, India.
Correspondence
Dr. Ashish Maheshwari,
Assistant Professor, Department of Transfusion Medicine, ILBS, New Delhi, India.
E-mail: dr.ashishmaheshwari@gmail.com
Neuromyelitis Optica (NMO) is a demyelinating inflammatory disorder of the spinal cord and optic nerve. As per American Society For Apheresis (ASFA) guidelines, Therapeutic Plasma Exchange (TPE) is considered as a second-line treatment in patients with weak or no response to steroid therapy. A patient of NMO presented to the tertiary care institute with a sudden loss of vision in the right eye. The patient was resistant to steroid treatment and improved significantly with TPE. Hence, TPE may be an effective treatment modality in steroid-resistant NMO with vision loss.
[
FULL TEXT ] | [ PDF]